Snakebite envenoming is an important public health issue responsible for mortality and
severe morbidity. Where mortality is mainly caused by venom toxins that induce …

Snakebite envenoming is a pathological condition which may occur in response to the
injection of venom. Snake venoms contain a complex mixture of biologically active …

Snakebites affect about 1.8 million people annually. The current standard of care involves
antibody-based antivenoms, which can be difficult to access and are generally not effective …

Snakebite envenoming kills and maims hundreds of thousands of people every year,
especially in the rural settings of tropical regions. Envenomings are still treated with animal …

Snakebite envenomations (SBEs) are a neglected medical condition of global importance
that mainly affect the tropical and subtropical regions. Clinical manifestations include pain …

Local tissue damage following snakebite envenoming remains a poorly researched area. To
develop better strategies to treat snakebites, it is critical to understand the mechanisms …

Snakebite envenoming results in∼ 100,000 deaths per year, with close to four times as
many victims left with life-long sequelae. Current antivenom therapies have several …

There are an estimated 5.4 million snakebite cases every year. People with snakebite
envenoming suffer from severe complications, or even death. Although some review articles …

Background Progress in snakebite envenoming (SBE) therapeutics has suffered from a
critical lack of data on the research and development (R&D) landscape. A database …

Snakebite is a neglected tropical disease that causes high rates of global mortality and
morbidity. Although snakebite can cause a variety of pathologies in victims, haemotoxic …